CVS Health Stock Price, News & Analysis (NYSE:CVS)

$69.69 -0.97 (-1.37 %)
(As of 02/21/2018 02:19 PM ET)
Previous Close$70.66
Today's Range$69.45 - $70.90
52-Week Range$66.45 - $84.00
Volume5.36 million shs
Average Volume8.95 million shs
Market Capitalization$70.51 billion
P/E Ratio10.76
Dividend Yield2.78%
Beta0.92

About CVS Health (NYSE:CVS)

CVS Health logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Retailers
Sub-IndustryDrug Retail
SectorNon-Cyclical Consumer Goods & Services
SymbolNYSE:CVS
CUSIP12665010
Phone+1-401-7651500

Debt

Debt-to-Equity Ratio0.59%
Current Ratio1.02%
Quick Ratio0.52%

Price-To-Earnings

Trailing P/E Ratio10.757341576507
Forward P/E Ratio10.92
P/E Growth1.22

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.38
Cash Flow$8.33 per share
Price / Cash8.37
Book Value$37.15 per share
Price / Book1.88

Profitability

Trailing EPS$6.47
Net Income$6.62 billion
Net Margins3.58%
Return on Equity17.21%
Return on Assets6.48%

Miscellaneous

Employees246,000
Outstanding Shares1,014,530,000

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Friday, December 29th. Shareholders of record on Wednesday, January 24th will be paid a dividend of $0.50 per share on Friday, February 2nd. This represents a $2.00 annualized dividend and a yield of 2.88%. The ex-dividend date of this dividend is Tuesday, January 23rd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Thursday, February, 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.88 by $0.04. The pharmacy operator earned $48.39 billion during the quarter, compared to analysts' expectations of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm's revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.71 EPS. View CVS Health's Earnings History.

When will CVS Health make its next earnings announcement?

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for CVS Health.

Where is CVS Health's stock going? Where will CVS Health's stock price be in 2018?

19 brokers have issued 12-month price targets for CVS Health's stock. Their predictions range from $73.00 to $106.67. On average, they anticipate CVS Health's share price to reach $88.43 in the next twelve months. View Analyst Ratings for CVS Health.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board (Age 63)
  • Larry J. Merlo, President, Chief Executive Officer, Director (Age 61)
  • David M. Denton, Chief Financial Officer, Executive Vice President (Age 52)
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President (Age 61)
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President (Age 61)
  • Stephen J. Gold, Executive Vice President, Chief Information Officer (Age 57)
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer (Age 53)
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • J. David Joyner, Executive Vice President (Age 52)
  • Robert O. Kraft, Executive Vice President (Age 47)

Who owns CVS Health stock?

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.61%), Barrow Hanley Mewhinney & Strauss LLC (1.53%), Franklin Resources Inc. (1.21%), Geode Capital Management LLC (1.07%), Bank of New York Mellon Corp (1.06%) and Macquarie Group Ltd. (0.91%). Company insiders that own CVS Health stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Who sold CVS Health stock? Who is selling CVS Health stock?

CVS Health's stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Amundi Pioneer Asset Management Inc., American Century Companies Inc., Alliancebernstein L.P., Credit Agricole S A, International Value Advisers LLC, TCW Group Inc. and Franklin Resources Inc.. Company insiders that have sold CVS Health company stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Who bought CVS Health stock? Who is buying CVS Health stock?

CVS Health's stock was acquired by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, American International Group Inc., Old Mutual Global Investors UK Ltd., The Manufacturers Life Insurance Company , BlackRock Inc., Renaissance Technologies LLC, APG Asset Management N.V. and Two Sigma Advisers LP. View Insider Buying and Selling for CVS Health.

How do I buy CVS Health stock?

Shares of CVS Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS Health stock can currently be purchased for approximately $69.50.

How big of a company is CVS Health?

CVS Health has a market capitalization of $70.51 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $6.47 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is 1 Cvs Dr, WOONSOCKET, RI 02895-6146, United States. The pharmacy operator can be reached via phone at +1-401-7651500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  921 (Vote Outperform)
Underperform Votes:  421 (Vote Underperform)
Total Votes:  1,342
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CVS Health (NYSE:CVS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.742.702.632.60
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $88.43$87.77$85.51$91.09
Price Target Upside: 25.33% upside10.41% upside23.89% upside20.83% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/13/2018CitigroupSet Price TargetNeutral -> Neutral$80.00 -> $77.00LowView Rating Details
2/9/2018Leerink SwannSet Price TargetOutperform -> Buy$90.00 -> $85.00LowView Rating Details
2/9/2018Robert W. BairdLower Price TargetNeutral -> Neutral$85.00 -> $80.00LowView Rating Details
2/8/2018Royal Bank of CanadaSet Price TargetBuy$89.00MediumView Rating Details
2/9/2018Needham & Company LLCSet Price TargetStrong-Buy -> Buy$100.00 -> $98.00MediumView Rating Details
1/24/2018MizuhoSet Price TargetBuy$95.00LowView Rating Details
1/18/2018CowenReiterated RatingOutperform$81.00 -> $99.00LowView Rating Details
1/5/2018SunTrust BanksBoost Price TargetBuy$90.00HighView Rating Details
1/5/2018Morgan StanleyUpgradeEqual Weight -> Overweight$88.00HighView Rating Details
1/4/2018Raymond James FinancialUpgradeOutperform -> Strong-Buy$90.00HighView Rating Details
12/26/2017Tigress FinancialReiterated RatingBuyLowView Rating Details
12/5/2017Deutsche BankReiterated RatingBuy -> HoldMediumView Rating Details
12/4/2017Jefferies GroupSet Price TargetHold$76.00MediumView Rating Details
12/4/2017Loop CapitalSet Price TargetHold$73.00MediumView Rating Details
10/9/2017OppenheimerReiterated RatingBuy$95.00N/AView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
2/28/2017Bank of AmericaReiterated RatingBuy$106.67N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016BarclaysReiterated RatingBuy$85.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$1.34N/AView Earnings Details
2/8/2018Q4 2017$1.88$1.92$47.54 billion$48.39 billionViewListenView Earnings Details
11/6/2017Q3 2017$1.49$1.50$46.17 billion$46.18 billionViewN/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
2/8/2012Q4 2011$0.89$0.89ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
11/3/2010Q3 2010$0.64$0.65ViewN/AView Earnings Details
7/28/2010Q2 2010$0.68$0.65ViewN/AView Earnings Details
5/4/2010Q1 2010$0.58$0.60ViewN/AView Earnings Details
2/8/2010Q4 2009$0.78$0.79ViewN/AView Earnings Details
11/5/2009Q3 2009$0.64$0.65ViewN/AView Earnings Details
8/4/2009Q2 2009$0.64$0.65ViewN/AView Earnings Details
5/5/2009Q1 2009$0.54$0.55ViewN/AView Earnings Details
2/19/2009Q4 2008$0.69$0.70ViewN/AView Earnings Details
10/30/2008Q3 2008$0.59$0.60ViewN/AView Earnings Details
7/31/2008Q2 2008$0.60$0.60ViewN/AView Earnings Details
5/1/2008Q1 2008$0.54$0.55ViewN/AView Earnings Details
1/31/2008Q4 2007$0.55$0.58ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$1.10$1.49$1.29
Q2 20185$1.43$1.63$1.56
Q3 20184$1.32$1.91$1.62
Q4 20184$1.93$1.99$1.97
Q1 20192$1.06$1.24$1.15
Q2 20192$1.26$1.59$1.43
Q3 20191$1.43$1.43$1.43
(Earnings estimates data provided by Zacks Investment Research)

Dividends

CVS Health (NYSE:CVS) Dividend Information

Most Recent Dividend:2/2/2018
Annual Dividend:$2.00
Dividend Yield:2.87%
Dividend Growth:22.10% (3 Year Average)
Payout Ratio:30.91% (Trailing 12 Months of Earnings)
31.35% (Based on This Year's Estimates)
29.81% (Based on Next Year's Estimates)
Track Record:10 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/29/2017quarterly$0.502.72%1/23/20181/24/20182/2/2018
9/19/2017quarterly$0.502.48%10/23/201710/24/201711/3/2017
7/6/2017quarterly$0.502.54%7/20/20177/24/20178/3/2017
3/2/2017quarterly$0.502.47%4/19/20174/21/20175/1/2017
12/22/2016quarterly$0.502.54%1/20/20171/24/20172/2/2017
9/22/2016quarterly$0.431.88%10/20/201610/24/201611/3/2016
7/6/2016quarterly$0.431.78%7/19/20167/21/20168/1/2016
3/2/2016quarterly$0.431.71%4/20/20164/22/20165/2/2016
12/16/2015quarterly$0.431.79%1/20/20161/22/20162/2/2016
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015
9/24/2014quarterly$0.281.38%10/21/201410/23/201411/3/2014
7/10/2014quarterly$0.281.43%7/17/20147/21/20148/1/2014
3/6/2014quarterly$0.281.5%4/17/20144/22/20145/2/2014
12/18/2013quarterly$0.281.57%1/21/20141/23/20142/3/2014
9/25/2013quarterly$0.231.55%10/17/201310/21/201311/1/2013
7/10/2013quarterly$0.231.48%7/18/20137/22/20138/2/2013
3/6/2013quarterly$0.231.73%4/19/20134/23/20135/3/2013
12/13/2012quarterly$0.231.83%1/22/20131/24/20132/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 83.23%
Insider Trades by Quarter for CVS Health (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2017Lisa BisacciaEVPSell29,445$75.00$2,208,375.0015,556View SEC Filing  
10/2/2017Thomas M MoriartyEVPSell20,547$81.17$1,667,799.9943,178View SEC Filing  
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02119,555View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.2084,337View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50299,255View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70141,096View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.8770,102View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.003,258View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.0059,301View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.3659,300View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00176,983View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.7794,309View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.4041,614View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.6022,801View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24250,335View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.0089,955View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00280,381View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.0069,601View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.0042,048View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00261,287View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.3075,315View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02561,059View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00161,613View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.0043,858View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.086,998View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.1156,187View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.5085,869View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52219,871View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.1240,563View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00408,649View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.0027,233View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.0756,187View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.5019,448View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.007,897View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.203,128View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CVS Health (NYSE CVS) News Headlines

Source:
DateHeadline
Albertsons Might Be Buying a Lemon in Rite AidAlbertsons Might Be Buying a Lemon in Rite Aid
finance.yahoo.com - February 21 at 5:13 AM
CVS Health Corp (CVS) Receives Average Rating of "Buy" from BrokeragesCVS Health Corp (CVS) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 20 at 4:28 PM
Rite Aid Was Albertsonss Last Best Hope - BloombergRite Aid Was Albertsons's Last Best Hope - Bloomberg
www.bloomberg.com - February 20 at 3:07 PM
Walgreens, Facebook and Apple Were Hot 4Q Stock Picks: 13FWalgreens, Facebook and Apple Were Hot 4Q Stock Picks: 13F
finance.yahoo.com - February 19 at 3:05 PM
Pharmacy Services Aid CVS Health, Aetna Deal an Upside Too - NasdaqPharmacy Services Aid CVS Health, Aetna Deal an Upside Too - Nasdaq
www.nasdaq.com - February 15 at 3:10 PM
Pharmacy Services Aid CVS Health, Aetna Deal an Upside TooPharmacy Services Aid CVS Health, Aetna Deal an Upside Too
finance.yahoo.com - February 15 at 3:10 PM
Would Acquiring AmerisourceBergen Make Sense for Walgreens?Would Acquiring AmerisourceBergen Make Sense for Walgreens?
finance.yahoo.com - February 15 at 3:10 PM
Metrics for Sales Growth Make CVS Health (CVS) a Sell at recent price of $70.11 - Investorplace.comMetrics for Sales Growth Make CVS Health (CVS) a Sell at recent price of $70.11 - Investorplace.com
investorplace.com - February 14 at 3:10 PM
The Zacks Analyst Blog Highlights: Broadcom, Canadian National, CVS Health, Aflac and DXC TechnologThe Zacks Analyst Blog Highlights: Broadcom, Canadian National, CVS Health, Aflac and DXC Technolog
finance.yahoo.com - February 14 at 3:10 PM
Analyzing the Top Losers in the Consumer Sector Last WeekAnalyzing the Top Losers in the Consumer Sector Last Week
finance.yahoo.com - February 14 at 3:10 PM
Metrics for Sales Growth Make CVS Health (CVS) a Sell at recent price of $70.11Metrics for Sales Growth Make CVS Health (CVS) a Sell at recent price of $70.11
investorplace.com - February 14 at 10:30 AM
Where Is The Love For CVS?Where Is The Love For CVS?
seekingalpha.com - February 14 at 5:05 AM
CVS Health (CVS) Plans to Boost Hourly Minimum Wage RateCVS Health (CVS) Plans to Boost Hourly Minimum Wage Rate
finance.yahoo.com - February 14 at 5:05 AM
Top Analyst Reports for Broadcom, Canadian National & CVS HealthTop Analyst Reports for Broadcom, Canadian National & CVS Health
finance.yahoo.com - February 14 at 5:05 AM
5 Awesome Stock Picks That Will Survive a Choppy Market5 Awesome Stock Picks That Will Survive a Choppy Market
finance.yahoo.com - February 14 at 5:05 AM
CVS Health (CVS) PT Set at $77.00 by CitigroupCVS Health (CVS) PT Set at $77.00 by Citigroup
www.americanbankingnews.com - February 13 at 10:48 PM
CDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths RiseCDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths Rise
finance.yahoo.com - February 13 at 5:09 AM
Walgreens-AmerisourceBergen Takeover Talk Follows Transformative DealsWalgreens-AmerisourceBergen Takeover Talk Follows Transformative Deals
finance.yahoo.com - February 13 at 5:09 AM
Is Amazon The End Of This Retailer? - Seeking AlphaIs Amazon The End Of This Retailer? - Seeking Alpha
seekingalpha.com - February 12 at 3:07 PM
Oppenheimer Equities Analysts Reduce Earnings Estimates for CVS Health Corp (CVS)Oppenheimer Equities Analysts Reduce Earnings Estimates for CVS Health Corp (CVS)
www.americanbankingnews.com - February 12 at 4:44 AM
Q1 2018 Earnings Forecast for CVS Health Corp Issued By SunTrust Banks (CVS)Q1 2018 Earnings Forecast for CVS Health Corp Issued By SunTrust Banks (CVS)
www.americanbankingnews.com - February 12 at 2:36 AM
Stocks That Fell to 3-Year Lows in the Week of Feb. 9Stocks That Fell to 3-Year Lows in the Week of Feb. 9
finance.yahoo.com - February 11 at 3:13 PM
CVS Health (CVS) PT Set at $89.00 by Royal Bank of CanadaCVS Health (CVS) PT Set at $89.00 by Royal Bank of Canada
www.americanbankingnews.com - February 10 at 4:10 PM
CVS to Raise Employee Pay and Offer Four Weeks Paid Parental LeaveCVS to Raise Employee Pay and Offer Four Weeks Paid Parental Leave
finance.yahoo.com - February 10 at 5:07 AM
CVS Health (CVS) Given a $85.00 Price Target by Leerink Swann AnalystsCVS Health (CVS) Given a $85.00 Price Target by Leerink Swann Analysts
www.americanbankingnews.com - February 10 at 12:52 AM
CVS Health (CVS) Price Target Cut to $80.00CVS Health (CVS) Price Target Cut to $80.00
www.americanbankingnews.com - February 10 at 12:52 AM
CVS Health is Oversold - NasdaqCVS Health is Oversold - Nasdaq
www.nasdaq.com - February 9 at 3:10 PM
US Companies Give Back as a Result of Tax OverhaulUS Companies Give Back as a Result of Tax Overhaul
finance.yahoo.com - February 9 at 3:10 PM
CVS Health (CVS) Stock Rating Lowered by Needham & Company LLCCVS Health (CVS) Stock Rating Lowered by Needham & Company LLC
www.americanbankingnews.com - February 9 at 8:30 AM
CVS Health (CVS) Q4 Earnings Beat Estimates, 18 View Upbeat - NasdaqCVS Health (CVS) Q4 Earnings Beat Estimates, '18 View Upbeat - Nasdaq
www.nasdaq.com - February 9 at 5:01 AM
CVS fourth quarter profit jumps in wake of US tax law - ReutersCVS fourth quarter profit jumps in wake of US tax law - Reuters
www.reuters.com - February 9 at 5:01 AM
Tax Reform Lifts CVS Health Corporation in 4th Quarter, but Dents Its 2018 Outlook - Motley FoolTax Reform Lifts CVS Health Corporation in 4th Quarter, but Dents Its 2018 Outlook - Motley Fool
www.fool.com - February 9 at 5:01 AM
Aetna Who? CVS Blows Wall Street Away With Its EarningsAetna Who? CVS Blows Wall Street Away With Its Earnings
finance.yahoo.com - February 9 at 5:01 AM
CVS Health (CVS) Beats On Q4 Earnings & Revenues EstimatesCVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates
finance.yahoo.com - February 8 at 3:09 PM
CVS profits nearly double after savings from the new tax lawCVS profits nearly double after savings from the new tax law
www.businessinsider.com - February 8 at 3:09 PM
CVS to raise minimum wage of workers; profit beatsCVS to raise minimum wage of workers; profit beats
finance.yahoo.com - February 8 at 3:09 PM
CVS: 'We're Going To Deliver' What Amazon, JPMorgan, Berkshire Seek To DoCVS: 'We're Going To Deliver' What Amazon, JPMorgan, Berkshire Seek To Do
finance.yahoo.com - February 8 at 3:09 PM
CVS Earnings Yield Boosts to Starting Pay, BenefitsCVS Earnings Yield Boosts to Starting Pay, Benefits
finance.yahoo.com - February 8 at 3:09 PM
CVS pledges to reinvest much of its tax savings, shares fallCVS pledges to reinvest much of its tax savings, shares fall
finance.yahoo.com - February 8 at 3:09 PM
CVS Health eyes data, wage boosts with $1.5B tax benefitCVS Health eyes data, wage boosts with $1.5B tax benefit
finance.yahoo.com - February 8 at 3:09 PM
CVS Health Falls Despite Earnings BeatCVS Health Falls Despite Earnings Beat
finance.yahoo.com - February 8 at 3:09 PM
How CVS Plans to Use Its Deal for Aetna to Transform Into AppleHow CVS Plans to Use Its Deal for Aetna to Transform Into Apple
finance.yahoo.com - February 8 at 3:09 PM
CVS scores $1.5 billion boost, plans to up wages and reduce Aetna debtCVS scores $1.5 billion boost, plans to up wages and reduce Aetna debt
finance.yahoo.com - February 8 at 3:09 PM
CVS Health CEO On Amazon-Berkshire Threat: Weve Got ThisCVS Health CEO On Amazon-Berkshire Threat: We've Got This
finance.yahoo.com - February 8 at 3:09 PM
Tax Reform Lifts CVS Health Corporation in 4th Quarter, but Dents Its 2018 OutlookTax Reform Lifts CVS Health Corporation in 4th Quarter, but Dents Its 2018 Outlook
finance.yahoo.com - February 8 at 3:09 PM
Dow Plunges 500 Points as Volatility Spikes, Bond Yields RiseDow Plunges 500 Points as Volatility Spikes, Bond Yields Rise
finance.yahoo.com - February 8 at 3:09 PM
CVS Health (CVS) Announces Quarterly  Earnings ResultsCVS Health (CVS) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 8 at 1:44 PM
CVS Health shares rise after earnings and revenue beat guidance - MarketWatchCVS Health shares rise after earnings and revenue beat guidance - MarketWatch
www.marketwatch.com - February 8 at 8:01 AM
CVS Health Corp. Q4 Income Rises - NasdaqCVS Health Corp. Q4 Income Rises - Nasdaq
www.nasdaq.com - February 8 at 8:01 AM
CVS Health Has Had Sick Looking Charts While Worrying About Amazon And Buying AetnaCVS Health Has Had Sick Looking Charts While Worrying About Amazon And Buying Aetna
finance.yahoo.com - February 7 at 3:08 PM

SEC Filings

CVS Health (NYSE:CVS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CVS Health (NYSE:CVS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CVS Health (NYSE CVS) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.